The PrisMax System - Baxter International extends care for chronic kidney patients

{
  "signal_id": "b1949db6-daf1-8132-5224-e1ece8aded67",
  "signal_type": "news",
  "signal_subtype": "launches",
  "detected_at": "2026-07-05T05:50:19+00:00",
  "company": {
    "name": "Baxter",
    "domain": "baxter.com"
  },
  "data": {
    "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/the-prismax-system-baxter-international-extends-care-for-chronic-kidney/69693355",
    "title": "The PrisMax System - Baxter International extends care for chronic kidney patients - AD HOC NEWS",
    "excerpt": "By Julian Reed, ad hoc news Classics & Longsellers Desk. Reviewed July 05, 2026, 1:50 AM ET. Details in the imprint . PrisMax System from Baxter International sits under a halo of soft monitor light in an ICU bay, its touchscreen glowing next to a sleeping patient on continuous dialysis. A nurse scrolls through therapy settings with gloved fingers, the quiet hum of the pump mixing with ventilator sounds. PrisMax System is Baxter International's platform for continuous renal replacement therapy, a form of dialysis used for critically ill patients with acute kidney injury who cannot tolerate traditional intermittent dialysis. The system is designed to deliver therapies such as continuous venovenous hemofiltration and hemodiafiltration with fine-grained control over fluid removal and solute clearance. According to Baxter, PrisMax provides clinicians with advanced monitoring, digital prescription guidance and flexible software options to adapt therapy to each patient. It integrates with Baxter's dedicated CRRT sets and solutions, including premixed dialysate and replacement fluids intended to simplify workflows in the intensive care unit. Get additional details on Baxter International's renal care portfolio and its role in intensive care medicine. PrisMax System is cleared for use in the United States and is marketed primarily to hospitals with intensive care units that treat...",
    "product": "PrisMax System",
    "summary": "Baxter International has launched the PrisMax System, a platform for continuous renal replacement therapy (CRRT) designed for critically ill patients with acute kidney injury.",
    "location": "United States",
    "planning": false,
    "image_url": "https://mdb.ad-hoc-news.de/bild/bild-2405013_1200_800.webp",
    "confidence": 0.9,
    "product_data": {
      "name": "PrisMax System",
      "full_text": "PrisMax System from Baxter International",
      "fuzzy_match": false
    },
    "product_tags": [
      "medical",
      "general_technology"
    ],
    "published_at": "2026-07-05T05:50:19Z",
    "location_data": [
      {
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "PrisMax System is Baxter International's platform for continuous renal replacement therapy, a form of dialysis used for critically ill patients with acute kidney injury who cannot tolerate traditional intermittent dialysis."
  }
}

curl https://signals.autobound.ai/v1/signals/b1949db6-daf1-8132-5224-e1ece8aded67 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"baxter.com","limit":20}'